Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended-Release Methylphenidate in Adults with ADHD (EMMA)
NCT00619840Phase 3Completed
- Sponsor
- Medice
- Start
- Nov 2004
- Primary completion
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of methylphenidate hydrochloride extended-release chewable tablet in attention deficit hyperactivity disorder (ADHD), sponsored by Medice. Started Nov 2004; status: completed.
02
Drugs
methylphenidate hydrochloride extended-release chewable tablet
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00619840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00619840.